Fluoroquinolone resistance in multidrug-resistant Mycobacterium tuberculosis independent of fluoroquinolone use

Yang Che, Qifa Song, Tianchi Yang, Guohua Ping, Mei Yu

Source: Eur Respir J, 50 (6) 1701633; 10.1183/13993003.01633-2017
Journal Issue: December
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Yang Che, Qifa Song, Tianchi Yang, Guohua Ping, Mei Yu. Fluoroquinolone resistance in multidrug-resistant Mycobacterium tuberculosis independent of fluoroquinolone use. Eur Respir J, 50 (6) 1701633; 10.1183/13993003.01633-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evaluation of macrolides for possible use against multidrug-resistant Mycobacterium tuberculosis
Source: Eur Respir J 2015; 46: 444-455
Year: 2015



Shortened multidrug-resistant tuberculosis regimens overcome low-level fluoroquinolone resistance
Source: Eur Respir J, 49 (6) 1700223; 10.1183/13993003.00223-2017
Year: 2017



Express-diagnosing of multidrug resistant bacterial and L-forms of mycobacterium tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 721s
Year: 2004

Linezolid in multidrug-resistant tuberculosis treatment
Source: Eur Respir J 2004; 24: Suppl. 48, 485s
Year: 2004

Therapeutic drug monitoring and fluoroquinolones for multidrug-resistant tuberculosis
Source: Eur Respir J, 57 (4) 2004454; 10.1183/13993003.04454-2020
Year: 2021



Susceptibility of Mycobacterium tuberculosis strains to fluoquinolones, obtained from chronic patients with multidrug resistant pulmonary tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 315s
Year: 2001

Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patients
Source: Eur Respir J 2013; 42: 1614-1621
Year: 2013



Is bedaquiline as effective as fluoroquinolones in the treatment of multidrug-resistant tuberculosis?
Source: Eur Respir J 2016; 48: 582-585
Year: 2016


Mycobacterium tuberculosis resistance
Source: Eur Respir J 2002; 20: Suppl. 38, 360s
Year: 2002

In-vitro and in-vivo activity of rifampicin and rifabutin against multi-drug-resistant strains of mycobacterium tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 567s
Year: 2002

Resistance genotypes of multidrug-resistant Mycobacterium tuberculosis isolates in Serbia
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019

Amikacin exposure and susceptibility of macrolide-resistant Mycobacterium abscessus
Source: ERJ Open Res, 5 (2) 00154-2018; 10.1183/23120541.00154-2018
Year: 2019



Evaluation of co-trimoxazole in the treatment of multidrug-resistant tuberculosis
Source: Eur Respir J 2013; 42: 504-512
Year: 2013



Multi-drug resistance tuberculosis in Greece
Source: Eur Respir J 2003; 22: Suppl. 45, 344s
Year: 2003

Circulation of multidrug resistant strains of Mycobacterium tuberculosis in Abkhasia
Source: Annual Congress 2006 - Epidemiology and management of multidrug-resistant tuberculosis (MDR-TB)
Year: 2006


In vitro synergy between linezolid and clarithromycin against Mycobacterium tuberculosis
Source: Eur Respir J 2014; 44: 808-811
Year: 2014


Drug resistance of Mycobacterium tuberculosis to fluoroquinolones (Q)
Source: Eur Respir J 2003; 22: Suppl. 45, 41s
Year: 2003

Mefloquine as a potential drug against multidrug-resistant tuberculosis
Source: Eur Respir J 2015; 46: 1503-1505
Year: 2015


Potential antimicrobial agents for the treatment of multidrug-resistant tuberculosis
Source: Eur Respir J 2014; 43: 884-897
Year: 2014



Considerations upon the drug resistance spectrum of Mycobacterium tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 313s
Year: 2001